baber/WOPTO huggingface dataset:
Patent EP-3526126-A1 (EP)
Inventor: VAN RIJSEWIJK LUCAS
IPC: B65C3/06
Filed: 2017-10-12
Abstract: The present disclosure relates to a device (22) for arranging folds (3, 3') in a strip of flattened tubular shrink foil material (13) in a container sleeving system (10) for applying tubular shrink foil material around containers (27). The device comprises a guiding element (22) comprising: • - an upstream guiding element part (41) formed by a first flat plate extending in a first plane; • - a downstream guiding element part (42) formed by a second flat plate part extending in a second plane rotated with respect to the first plane; • - an intermediate guiding element part (43) connected to or integrally formed with the upstream and downstream guiding element parts and shaped so as to smoothly guide the flattened tubular shrink foil material moving over the first flat plate towards the second flat plate; • - pressure rollers (90, 107; 91, 108) arranged configured to press at least one additional fold into the tubular shrink foil material.
Patent EP-3532379-A1 (EP)
Inventor: MORGAN BRIAN
IPC: B64C39/02
Filed: 2017-10-27
Abstract: A modular payload airframe section for an aircraft airframe is disclosed. The modular payload airframe section comprises: a storage volume for receiving a payload; a releasable fixation means for releasably affixing the modular payload airframe section to an airframe of the aircraft; and wherein the modular payload airframe section forms at least part of a nose-cone of the aircraft airframe when affixed thereto.
Patent EP-3456532-A1 (EP)
Inventor: IWAKI Banri
IPC: B32B27/32
Filed: 2017-05-08
Abstract: The present invention is for packaging and accommodating a medicine or bulk drug thereof for storage/transportation of the same in a state in which high quality is maintained, and provides a medical packaging film whereby multi-weight packaging of medicines and the like is possible while adequate antistatic function is imparted, and amounts of an ignition residue and an elutable alkali component are reduced to within a standard specification. The present invention relates to a medical packaging film comprising a layered body of at least three thermoplastic resin formation layers, wherein the layered body of a first layer which is an innermost layer in contact with a medicine and comprising a thermoplastic resin formation layer not containing an antistatic agent, a second layer comprising a thermoplastic resin formation layer containing a polymer-type antistatic agent including a specific amount of a potassium ionomer polymer-type antistatic agent in a single layer, and layers from a third layer to an outermost layer or a third layer as an outermost layer comprising a thermoplastic resin formation layer has a specific amount of a water-elutable alkali component, and the thickness L 1  of the first layer, the C' 2  vol% of the potassium ionomer concentration in the second layer, and the thickness L 2  of the second layer satisfy a specific condition.
Patent EP-3545094-A1 (EP)
Inventor: HABERLAND ANNEKATHRIN
IPC: A61P25/00
Filed: 2017-10-27
Abstract: La présente invention concerne de nouvelles molécules aptamères destinées à être utilisées dans la thérapie d'un sujet par inhibition ou suppression de l'activation de TLR9 dans une cellule, un procédé d'inhibition ou de suppression de l'activation de TLR9 dans une cellule à l'aide de telles molécules aptamères, une composition pharmaceutique et un kit comprenant de telles molécules aptamères et l'utilisation de molécules aptamères pour inhiber ou supprimer l'activation TLR9.
Patent EP-3466970-A1 (EP)
Inventor: KIM YONG SUNG
IPC: C07K5/087
Filed: 2017-05-26
Abstract: The present disclosure relates to a cytosol-penetrating antibody and the use thereof, and more specifically to identification of a structural mechanism that induces escape from endosomes into the cytosol after cellular internalization into living cells through a cell membrane protein, a light-chain variable region and/or heavy-chain variable region, which is based on this identification and has a significantly improved ability to escape from endosomes into the cytosol, a cytosol-penetrating antibody comprising the same, a method for producing the same, and the use thereof.
Patent EP-3455864-A1 (EP)
Inventor: ALLEN MARK GEORGE
IPC: B32B3/00
Filed: 2017-05-25
Abstract: L'invention concerne des noyaux magnétiques feuilletés, des procédés de fabrication de noyaux magnétiques feuilletés et des dispositifs électriques utilisant des noyaux magnétiques feuilletés. Dans certains exemples, un procédé de fabrication d'un noyau magnétique feuilleté comprend le dépôt d'une première couche magnétique et le dépôt d'une couche inter-tôles sur la première couche magnétique. La couche inter-tôles comprend un matériau partiellement conducteur présentant une conductivité supérieure ou égale à 10 -4  S/cm et inférieure ou égale à 10 5  S/cm. Le procédé comprend le dépôt d'une seconde couche magnétique sur la couche inter-tôles. Le procédé peut comprendre le dépôt séquentiel de couches inter-tôles supplémentaires et de couches magnétiques supplémentaires d'une manière alternée afin de produire le noyau magnétique feuilleté.
Patent EP-3532520-A1 (EP)
Inventor: BARTHOLOMEW ERIC L
IPC: C08F293/00
Filed: 2017-10-25
Abstract: Acrylic copolymers that include the controlled placement of particular functional groups within the polymer structure are provided. The copolymers comprise a first reactive segment of including a functional group selected from the group consisting of a UV active functional group, a reactive functional group, a non-reactive functional group, and combinations thereof and a second segment including a functional group selected from the group consisting of a reactive functional group, a non- reactive functional group, and combinations thereof. The acrylic copolymers are manufactured via a controlled radical polymerization process. The copolymers are useful in the manufacture of adhesives and elastomers.
Patent EP-3552344-A1 (EP)
Title: Bidirektional verkettete blockchainstruktur
Inventor: KOMAROV ILYA
IPC: H04L9/32
Filed: 2017-12-05
Abstract: Die Erfindung betrifft ein Verfahren zum manipulationssicheren Speichern von Daten (214) in einer bidirektional verketteten Blockchainstruktur (100, 101). Das Verfahren umfasst: - Erzeugen eines zusätzlichen Blocks (102) für die Blockchainstruktur (100), welcher die zu speichernden Daten (214) umfasst, - Erzeugen einer ersten blockabhängigen bidirektionalen Verkettungsfunktion (112) aus der blockunabhängigen Verkettungsfunktion (110), wobei für die Erzeugung ein Dateninhalt des letzten Blocks (103) der Blockchainstruktur (100) als ein erster Parameter und ein Dateninhalt des zusätzlichen Blocks (102) für die Blockchainstruktur (100) als ein zweiter Parameter der blockunabhängigen Verkettungsfunktion (110) verwendet werden, sodass die erzeugte ersten blockabhängigen bidirektionalen Verkettungsfunktion (112) paarweise sowohl von dem letzten Block (103) der Blockchainstruktur (100) als auch von dem zusätzlichen Block (102) für die Blockchainstruktur (100) abhängig ist, - bidirektionales Verketten des letzten Blocks (103) der Blockchainstruktur (100) mit dem zusätzlichen Block (102) für die Blockchainstruktur (100), wobei das bidirektionales Verketten ein Transformieren des letzten Blocks (103) der Blockchainstruktur (100) in ein erstes Chiffrat unter Verwendung der ersten blockabhängigen bidirektionalen Verkettungsfunktion (112) und ein Transformieren des zusätzlichen Blocks (102) für die Blockchainstruktur (100) unter Verwendung der ersten blockabhängigen bidirektionalen Verkettungsfunktion (112) in ein zweites Chiffrat umfasst, - Speichern der resultierenden erweiterten Blockchainstruktur (101), welche das erste und das zweite Chiffrat umfasst.
Patent EP-3532616-A1 (EP)
Inventor: FRIEDLAND ARI E
IPC: C12N15/113
Filed: 2017-10-27
Abstract: La présente invention concerne des systèmes d'édition de génome et des constructions génétiques qui ciblent un gène viral du virus de l'herpès simplex (VHS) comprenant une molécule Cas9, et une molécule d'ARNg, et des compositions et des cellules comprenant ces systèmes d'édition de génome et ces constructions génétiques. L'invention concerne également des procédés d'utilisation des systèmes d'édition de génome, des constructions génétiques, des compositions et des cellules pour l'ingénierie génomique (par exemple, la modification d'un gène viral de VHS), et pour la prévention, le traitement ou la réduction d'une infection par le VHS.
Patent EP-3555514-A1 (EP)
Inventor: CLEMENTS RICHARD ALASDAIR
IPC: F16L33/01
Filed: 2017-12-11
Abstract: A method and apparatus are disclosed. The apparatus includes a securing element body comprising a first elongate weakened region in the body extending along a respective first weakened region axis, a further elongate weakened region substantially orthogonal to the first weakened region axis and located proximate to a first end of the first weakened region, and a still further elongate weakened region substantially orthogonal to the first weakened region axis and located proximate to a remaining end of the first weakened region, wherein the further and still further weakened regions are disposed in a substantially parallel spaced apart relationship to provide at least one deformable region in the securing element body on a respective side of the first elongate weakened region.
Patent EP-3732548-A1 (EP)
Inventor: LINDEN ERIK
IPC: G06F3/01
Filed: 2017-12-28
Abstract: A method of controlling exposure time is disclosed comprising receiving an image of an eye from an image sensor, the image resulting from the image sensor detecting light during a first exposure time. A pupil intensity is determined as an intensity of a representation of a pupil of the eye in the image and an iris intensity is determined as an intensity of a representation of an iris of the eye in the image. Furthermore, a pupil-iris contrast is determined as a contrast between the representation of the pupil in the image and the representation of the iris in the image. On a condition that the pupil intensity is determined to meet an intensity condition, an intensity compensated exposure time is determined which is different from the first exposure time, and on a condition that the pupil-iris contrast is determined to meet a contrast condition, a contrast compensated exposure time is determined which is different from the first exposure time. Furthermore, a second exposure time is set based on any determined intensity compensated exposure time and any determined contrast compensated exposure time.
Patent EP-3555111-A1 (EP)
Inventor: YANG MICHAEL G
IPC: C07F9/6509
Filed: 2017-12-12
Abstract: La présente invention concerne des composés de formule (I) : ou un stéréoisomère ou un sel pharmaceutiquement acceptable de ceux-ci, dans laquelle, tous les substituants sont tels que définis dans la description. Lesdits composés sont utiles dans la modulation d'IL-12, IL-23 et/ou IFNα en agissant sur Tyk-2 de manière à causer une inhibition de la transduction du signal.
Patent EP-3573928-A1 (EP)
Inventor: TAVAKKOLI BAHMAN
IPC: C09C1/02
Filed: 2017-12-20
Abstract: The present invention concerns a process for the preparation of fragmented natural calcium carbonate with a reduced content of impurities by use of a high voltage 5 fragmentation apparatus, as well as products obtained thereof and their use. Furthermore, the present invention refers to the use of a high voltage fragmentation apparatus and a separation step for reducing impurities in at least one natural calcium carbonate and impurities containing material.
Patent EP-3551733-A1 (EP)
Inventor: BRANDA PAOLO
IPC: C10J3/86
Filed: 2017-12-07
Abstract: A system (1) for transforming an organic material into syngas, comprising: an inlet (2) that can be supplied with said organic material and/or with a combustion agent; an outlet (3) that can be passed through by said syngas produced by said system (1) and can be fluidly connected with a user; an open reactor (5), interposed between said inlet (2) and said outlet (3), that can be supplied at a first height with said organic material, and adapted to provide said syngas at a second height, lower than said first height; and cooling means (30) positioned upstream of said outlet (3) and downstream of said reactor (5) according to a direction of feed of said syngas inside said system (1) and adapted to cool said syngas inside said system (1); said cooling means (30) comprise a tube heat exchanger (80) formed of a plurality of tubes (81) that can be passed through by said syngas and housed inside a bath (82) filled, in use, with a heat transfer liquid.
Patent EP-3484441-A1 (EP)
Inventor: OH SUNGWHAN
IPC: A61K9/127
Filed: 2017-07-15
Abstract: The invention provides immunostimulatory glycolipids and compositions thereof and methods of use thereof.
Patent EP-3505849-A1 (EP)
Inventor: ZHONG RUJIANG
IPC: F25B29/00
Filed: 2017-06-21
Abstract: A switching device (100) for a multi-split air conditioner, comprising: a housing (1), a gas-liquid separator (2), multiple first indoor unit interface pipes (3), at least one heat exchange component (4), and multiple second indoor unit interface pipes (5). The gas-liquid separator (2) is provided with an inlet (21) to an outdoor unit, a first outlet (22), and a second outlet (23). The multiple first indoor unit interface pipes (3) and the multiple second indoor unit interface pipes (5) are spaced from each other in a first direction. The first outlet (22) is connected to multiple first interfaces by means of the multiple first indoor unit interface pipes (3), respectively. The second indoor unit interface pipes (5) and the first indoor unit interface pipes (3) are spaced apart in a second direction. Some of the first indoor unit interface pipes (3) and some of the second indoor unit interface pipes (5) are spaced apart from the rest of the first indoor unit interface pipes (3) and the rest of the second indoor unit interface pipes (5) in the second direction. Moreover, also disclosed is a multi-split air conditioner having the switching device (100).
Patent EP-3501295-A1 (EP)
Inventor: YAMAZAKI YUICHIRO
IPC: A23L27/10
Filed: 2017-08-22
Abstract: The present invention relates to a perfume composition which contains at least one selected from the group consisting of (-)-mustakone, (+)-mustakone, and a mixture thereof, and which is to be added to a food and a beverage. As a result of the addition of the perfume composition to a food and a beverage, fruit pulp-like flavor, fruit juice-like flavor, or matured flavor can be provided or enhanced.
Patent EP-3505595-A1 (EP)
Inventor: NI YANG
IPC: C08L101/00
Filed: 2017-07-04
Abstract: A flame-retardant synthetic resin composition containing (A) 20 to 50 parts by mass of at least one melamine salt selected from the group consisting of melamine orthophosphate, melamine pyrophosphate, and melamine polyphosphate, (B) 50 to 80 parts by mass of at least one piperazine salt selected from the group consisting of piperazine orthophosphate, piperazine pyrophosphate, and piperazine polyphosphate, the sum of the components (A) and (B) being 100 parts by mass, and (C) 1 to 50 parts by mass of β-dextrin.
Patent EP-3509114-A1 (EP)
Inventor: ICHINOKURA HIROYASU
IPC: H01L33/52
Filed: 2017-08-10
Abstract: An optical semiconductor apparatus (10) includes: a package substrate (30); a light emitting device (20) housed in a recess (34) of the package substrate; a window member (40) provided to cover an opening of the recess (34); and a sealing structure (50) that seals a space between the package substrate (30) and the window member (40). The sealing structure (50) includes a first metal layer (51) provided on the package substrate, a second metal layer (52) provided on the window member (40), and a metal bonding part (53) provided between the first and second metal layers. An entirety of one of the first and second metal layers (51, 52) is positioned in a region where the other of the first and second metal layers (51, 52) is provided.
Patent EP-3395873-A1 (EP)
Inventor: KIM HYUN KYU
IPC: C08K5/10
Filed: 2017-09-05
Abstract: The present invention relates to a plasticizer composition and a resin composition including the same, and can provide a plasticizer composition in which a terephthalate-based material and a cyclohexane 1,4-diester-based material are mixed, and the sum of carbon atoms of alkyl groups bonded to the two materials is in the range of 34 to 40, and by which environmental friendliness can be secured, mechanical properties such as tensile strength and an elongation rate and physical properties such as migration properties and volatile loss can be improved to levels equal to or higher than those of existing products, and effects of improving processability and plasticizing efficiency can be expected, and a resin composition including the same.
Patent EP-3484510-A1 (EP)
Title: Protéases 3c modifiées du virus de la fièvre aphteuse, compositions et procédés associés
Inventor: RASMUSSEN MAX V
IPC: C07K14/005
Filed: 2017-08-28
Abstract: La présente invention concerne généralement des protéases 3C du virus de la fièvre aphteuse (FMDV) qui ont été modifiées par mutation d'une séquence polynucléotidique codant pour la protéase 3C de FMDV. Les protéases du virus de la fièvre aphteuse (FMDV) modifiées présentent une activité protéolytique sur la protéine précurseur du virus de la fièvre aphteuse (FMDV Fl) et présentent une réduction d'une ou plusieurs propriété(s toxique(s) ou inhibitrice(s) associée(s) à une protéase 3C du virus de la fièvre aphteuse (FMDV)non modifiée sur une cellule hôte utilisée pour sa production par recombinaison. Des vecteurs portant des polynucléotides codant pour des séquences de protéase 3C du virus de la fièvre aphteuse (FMDV) modifiées peuvent induire la production de particules pseudo-virales du virus de la fièvre aphteuse (FMDV) dans une cellule hôte lorsqu'elles sont exprimées dans la cellule hôte. Les protéases 3C du virus de la fièvre aphteuse (FMDV) modifiées peuvent généralement être utilisées pour produire des préparations immunogènes du virus de la fièvre aphteuse (FMDV) capables d'induire une réponse immunitaire contre le virus de la fièvre aphteuse (FMDV).
Patent EP-3543364-A1 (EP)
Inventor: KAWASAKI YOSHIYASU
IPC: C22C38/60
Filed: 2017-11-15
Abstract: To provide a high-strength steel sheet with excellent ductility and hole expansion formability, a yield ratio of less than 68 %, and a tensile strength of 590 MPa or more, by having a predetermined chemical composition and a microstructure where ferrite is 35 % or more and 80 % or less and martensite is 5 % or more and 25 % or less in area ratio, retained austenite is 8 % or more in volume fraction, the average grain size of ferrite, martensite and retained austenite is 6.0 µm or less, 3.0 µm or less and 3.0 µm or less respectively, the average aspect ratio of crystal grain of ferrite, martensite and retained austenite is each more than 2.0 and 15.0 or less, and the value obtained by dividing the Mn content (mass%) in retained austenite by the Mn content (mass%) in ferrite is 2.0 or more.
Patent EP-3546012-A1 (EP)
Inventor: KANEMASA KENICHI
IPC: A61M25/092
Filed: 2017-11-24
Abstract: The present disclosure provides a medical instrument, including a tubular main body; a plurality of operating lines; an operating part main body provided on the base end portion of the tubular main body; a bending operating part which is configured to bend a distal portion of the tubular main body; a path defining part which is configured to define a path of the operating line in the bending operating part; and a deviation preventive member which is configured to prevent the operating line from deviating from a path defined by the path defining part; wherein the operating line becomes in a relaxed state when the bending operating part is in a fixation position, while the operating line becomes in a strained state when the bending operating part is in an operation position.
Patent EP-3556964-A1 (EP)
Inventor: LI YUEMING
IPC: E04F21/22
Filed: 2017-08-07
Abstract: Disclosed are a ceramic tile leveling bracket, pushing and clamping pliers and a ceramic tile leveling and laying system. The ceramic tile leveling and laying system comprises: a ceramic tile leveling bracket (1), an insertion block (2) and pushing and clamping pliers (3), wherein the ceramic tile leveling bracket (1) is provided at the junction between two adjacent ceramic tiles (4), one end of the insertion block (2) is inserted into an insertion block through hole (16) of the ceramic tile leveling bracket (1), and the pushing and clamping pliers (3) push and clamp the insertion block (2) into the insertion block through hole (16), so that an insertion block bottom surface (21) is tangent to upper surfaces of the two ceramic tiles (4). The ceramic tile leveling and laying system is easy to operate, and helps to improve the laying efficiency and laying quality.
Patent EP-3490202-A1 (EP)
Inventor: KUANG GUANGCAI
IPC: H04L45/24
Filed: 2017-10-24
Abstract: Disclosed is a method and a device for optimizing load balancing based on cloud monitoring that relate to loading balancing and that can improve the primary/backup Availability Zone (AZ) switchover efficiency of an load balancing instance by intelligently switching the preferences of load balancing devices. The method includes: obtaining statistics on traffic distribution within a controlled area of a load balancing system, statistics on backend servers within a plurality of AZs of the load balancing system, and monitored network quality of the AZs; determining an AZ suitable to serve as a corresponding primary AZ of a load balancing instance based on the traffic distribution statistics, the backend server statistics, and the monitored network quality; and performing a primary AZ switchover of the load balancing instance based on the determined result. The present application is intended for the optimizing of load balancing.
Patent EP-3564668-A1 (EP)
Inventor: URANO HIKARU
IPC: G01N33/49
Filed: 2017-12-28
Abstract: An object of the present invention is to provide a blood analysis method and a blood test kit, which are for performing quantitative analysis of components by precisely obtaining a dilution factor. According to the present invention, provided is a blood analysis method including: a step of diluting a collected blood sample with a diluent solution; a step of determining a dilution factor by using a normal value of a normal component which is homeostatically present in blood; and a step of analyzing a concentration of a target component in the blood sample, in which the blood analysis method uses a member selected from the group consisting of a first storing instrument for storing the diluent solution, a collection instrument for collecting the blood, a separation instrument for separating and recovering blood plasma from the blood sample diluted with the diluent solution, a holding instrument for holding the separation instrument, and a second storing instrument for storing the recovered blood plasma, and in which the dilution factor is corrected after calculating in advance an amount of the normal component derived from the diluent solution, and/or an amount of the normal component derived from at least one of the members which may be contained in the diluent solution.
Patent EP-3648112-A1 (EP)
Title: Chemistry control system for power plant
Inventor: KRITSKIY VLADIMIR GEORGIEVICH
IPC: B08B3/00
Filed: 2017-06-30
Abstract: The power plant chemical control system includes at least one coolant electrochemical indication sensor (15) electrically connected to the measurement data processing and transmission unit (21) with its outlet connected to a central computer (22) controlling the actuation devices (23) and (24) for injection of hydrogen and chemical reagents. The sensor (15) is of a flow type with its hydraulic inlet connected by a sampling tube (13) to the power plant process circuit and its hydraulic outlet (15) hydraulically connected to the first heat exchanger (17) and to the first throttling device (18) with a reversible coolant supply circuit (19) in series.